semaglutide oral cardiovascular indication 2025 news outcomes of and tirzepatide for patients with type 2 diabetes in clinical practice Oral semaglutide lowers risk of

Central Nervous System Effects Perhaps most notably for weight management applications, semaglutide crosses the blood-brain barrier to act on GLP-1 receptors in the hypothalamus and brainstem, specifically targeting the arcuate nucleus and nucleus tractus solitarius

The press releases noted an increased risk of aspiration because semaglutide delays gastric emptying, making food sit in the stomach longer

Understanding the relationship between units and milligramsand how this translates to real weight loss outcomesis essential for anyone starting a GLP-1 therapy program

10.1056/NEJMoa2032183 67 WitkowskiM.WilkinsonL.WebbN.WeidsA.GlahD.VrazicH

Significant Weight Loss: Unexplained or rapid weight loss should be monitored and discussed with a healthcare provider to ensure it is a healthy and intended part of the treatment plan

Gastroparesis: Gastroparesis, or stomach paralysis, is a permanent condition that slows down the muscles and nerves in the stomach